Healthcare interactions prior to first hospital admission with alcohol-related liver disease.

Autor: Lewis H; Liver Unit, Imperial College NHS Healthcare Trust, St Marys Hospital London, London, UK., Parker R; Leeds Liver Unit, St James's University Hospital, Leeds, UK.; Discover-NOW, Imperial College Health Partners, London, UK., Ul-Haq Z; Discover-NOW, Imperial College Health Partners, London, UK., Lucas A; Discover-NOW, Imperial College Health Partners, London, UK., Cohen C; Discover-NOW, Imperial College Health Partners, London, UK., Vergis N; Digestive Diseases Division, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Thursz M; Digestive Diseases Division, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Jazyk: angličtina
Zdroj: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Sep; Vol. 44 (9), pp. 2273-2281. Date of Electronic Publication: 2024 May 21.
DOI: 10.1111/liv.15969
Abstrakt: Background and Aims: To examine the healthcare contacts of patients in the year before an index admission to hospital with alcohol-related liver disease (ArLD) to identify where opportunities for earlier identification of alcohol use disorders (AUD) and ArLD and intervention may occur.
Methods: A retrospective cohort study using the regional database encompassing NHS organisations across North West London (344 general practitioner [GP] practices, 4 acute hospital trusts and 2 mental health and community health trusts). Patients who had an index admission with ArLD were identified through healthcare coding and compared with a control cohort. Healthcare contacts, blood tests and AUD testing in the year preceding admission were measured.
Results: The ArLD cohort had 1494 participants with an index hospital admission with ArLD. The control cohort included 4462 participants. In the year preceding an index admission with ArLD, 91% of participants had at least one contact with primary care with an average of 2.97 (SD 2.45) contacts; 80% (n = 1199/1494) attended ED, 68% attended an outpatient clinic, and 42% (n = 628/1494) had at least one inpatient admission. Only 9% of the ArLD (137/1494) had formal testing for AUD. Abnormal bilirubin and platelets were more common in the ArLD than the control cohort 25% (138/560) and 28% (231/837), respectively, v 1% (12/1228) and 1% (20/1784).
Conclusions: Prior to an index admission with ArLD patients have numerous interactions with all healthcare settings, indicating missed opportunities for early identification and treatment.
(© 2024 The Authors. Liver International published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: